Intervention study of lung cancer patients undergoing postoperative chemotherapy based on sentinel symptoms

doi:10.3761/j.issn.0254-1769.2024.02.001

Abstract

Abstract:

Objective Based on sentinel symptoms，a nursing intervention program for gastrointestinal symptom group of postoperative chemotherapy for lung cancer was constructed and its application effect was evaluated. Methods The nursing intervention program of gastrointestinal symptom group was constructed on the basis of reference guidelines，qualitative interview and expert consultation. From January 2021 to January 2022，a total of 330 patients with postoperative chemotherapy for lung cancer in a tertiary hospital in Shenyang were selected as research subjects. The experimental group received the gastrointestinal symptoms group nursing intervention program on the basis of routine nursing，and the control group received routine care. Patients were investigated with the M.D. Anderson Symptom Inventory and the MOS 36-Item Short-Form Health Survey before 1st chemotherapy（T1），3rd chemotherapy（T2） and 5th chemotherapy（T3）. Results After the intervention，the total scores of the 2 groups and the total scores of each symptom in T2 and T3 were statistically significant（P<0.05），and the score of the experimental group was lower than that of the control group. For the scores of 6 dimensions of physiological function，physical pain，overall health，vitality，emotional function，mental health in 2 groups between different time points，the differences are statistically significant（P<0.05）. Conclusion The nursing intervention program of the gastrointestinal symptom group based on sentinel symptoms is beneficial to reduce the severity of the gastrointestinal symptom group and improve the quality of life for postoperative chemotherapy for lung cancer patients.

Key words: Lung Cancer, Symptom Cluster, Sentinel Symptoms, Nausea, Quality of Life, Nursing Care

摘要：

目的基于前哨症状构建肺癌术后化疗患者消化道症状群护理干预方案并评价其应用效果。方法在参照指南、质性访谈和专家咨询的基础上，构建消化道症状群护理干预方案。2021年1月—2022年1月，选取沈阳市某三级甲等医院肺癌术后化疗患者330例作为应用对象。试验组在常规护理的基础上接受消化道症状群护理干预方案，对照组接受常规护理。采取安德森症状评估量表、健康状况调查简表分别于第1次化疗前（T1）、第3次化疗前（T2）和第5次化疗前（T3）对患者进行评估。结果干预后，两组症状群总分、各症状得分及健康状况调查简表的生理职能、躯体疼痛、总体健康、活力、情感职能、精神健康维度得分存在组间和时间的交互效应（P<0.05）。简单效应分析结果显示，两组症状群总分、各症状得分及健康状况调查简表的生理职能、躯体疼痛、总体健康、活力、情感职能、精神健康维度得分在T2、T3时间比较，差异具有统计学意义（P<0.05）。结论基于前哨症状的消化道症状群护理干预方案，有利于减轻肺癌术后化疗患者消化道症状群的严重程度，并提高生活质量。

关键词: 肺癌, 症状群, 前哨症状, 恶心, 生活质量, 护理

MA Jingshuang, WANG Aiping, WANG Yanjie, LI Wei, LIU Yanxia. Intervention study of lung cancer patients undergoing postoperative chemotherapy based on sentinel symptoms[J]. Chinese Journal of Nursing, 2024, 59(2): 133-141.

马景双, 王爱平, 王艳杰, 李魏, 刘艳霞. 基于前哨症状的肺癌术后化疗患者护理干预方案的构建及应用[J]. 中华护理杂志, 2024, 59(2): 133-141.

Figures/Tables 4

Table 1 Nursing intervention program of gastrointestinal symptom group for postoperative chemotherapy for lung cancer patients

Table 2 Comparison of general data between 2 groups[case（percentage，%）]

Table 3 Comparison of gastrointestinal symptom clusters between the 2 groups（scores，$\bar{x}±s$）

Table 4 Comparison of scores of SF-36 in the 2 groups（scores，$\bar{x}±s$）

References 32

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI URL
[2]	Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer[J]. Oncol Nurs Forum, 2001, 28(3):465-470. PMID
[3]	陈庆梅, 崔妙玲, 麻月娥, 等. 慢性阻塞性肺疾病急性加重期患者症状群及前哨症状的调查研究[J]. 中华护理杂志, 2022, 57(23):2891-2897. DOI
	Chen QM, Cui ML, Ma YE, et al. Investigation of symptom clusters and sentinel symptoms in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Chin J Nurs, 2022, 57(23):2891-2897. DOI
[4]	Rha SY, Park M, Lee J. Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy[J]. Support Care Cancer, 2019, 27(5):1687-1695. DOI PMID
[5]	翟莹莹, 杨姮, 周文琴. 癌症患者症状群概述及管理措施研究现状[J]. 护理学报, 2019, 26(1):32-35.
	Zhai YY, Yang H, Zhou WQ. Overview of symptom groups of cancer patients and research status of management measures[J]. J Nurs China, 2019, 26(1):32-35.
[6]	王艳, 何瑞仙, 黄秀秀, 等. 1631例肺癌化疗患者症状簇的调查分析[J]. 中国肿瘤临床与康复, 2021, 28(2):138-143.
	Wang Y, He RX, Huang XX, et al. Symptom clusters in 1631 patients with lung cancer undergoing chemotherapy[J]. Chin J Clin Oncol Rehabil, 2021, 28(2):138-143.
[7]	马景双. 基于症状管理理论的非小细胞肺癌术后化疗患者症状群干预方案的构建及初步应用[D]. 沈阳: 中国医科大学, 2022.
	Ma JS. Construction and preliminary application of symptom cluster intervention program in postoperative chemotherapy patients with non-small cell lung cancer based on symptom management theory[D]. Shenyang: China Medical University, 2022.
[8]	马景双, 王爱平. 肺癌术后化疗患者症状群及前哨症状的调查[J]. 护理学报, 2021, 28(12):33-37.
	Ma JS, Wang AP. Symptom cluster and sentinel symptoms in lung cancer patients with postoperative chemotherapy[J]. J Nurs China, 2021, 28(12):33-37.
[9]	Ma JS, Xu H, Liu S, et al. An investigation of symptom clusters and sentinel symptoms during the first 2 cycles of postoperative chemotherapy in patients with lung cancer[J]. Cancer Nurs, 2022; 45(6):488-496. DOI PMID
[10]	秦莉媛, 侯晓婷, 杨萍. 肺癌患者症状群的研究进展[J]. 中华护理杂志, 2019, 54(1):119-124.
	Qin LY, Hou XT, Yang P. Progress in the symptom clusters of lung cancer patients[J]. Chin J Nurs, 2019, 54(1):119-124.
[11]	胡霞, 罗健, 李苗苗, 等. 肺癌患者症状群管理研究进展[J]. 护理学杂志, 2019, 34(7):99-102.
	Hu X, Luo J, Li MM, et al. Research progress on symptom cluster management in patients with lung cancer[J]. J Nurs Sci, 2019, 34(7):99-102.
[12]	侯黎莉, 顾芬, 周彩存. 经皮穴位电刺激预防肺癌患者化疗后骨髓抑制的效果观察[J]. 中华护理杂志, 2016, 51(1):57-61.
	Hou LL, Gu F, Zhou CC. Effect of percutaneous electrical stimulation on bone marrow suppression after chemotherapy in patients with lung cancer[J]. Chin J Nurs, 2016, 51(1):57-61.
[13]	Tralongo AC, Antonuzzo A, Pronzato P, et al. Management of chemotherapy-induced neutropenia in patients with cancer:2019 guidelines of the Italian Medical Oncology Association (AIOM)[J]. Tumori, 2020, 106(4):273-280. DOI URL
[14]	国家卫生健康委员会. 新型抗肿瘤药物临床应用指导原则(2019年版)[J]. 肿瘤综合治疗电子杂志, 2020, 6(1):16-47.
	The National Health Commission. Guidelines for the clinical application of new antitumor Drugs(2019 edition)[J]. J Multi-discip Cancer Manag Electron Version, 2020, 6(1):16-47.
[15]	Cury-Martins J, Eris APM, Abdalla CMZ, et al. Management of dermatologic adverse events from cancer therapies:recommendations of an expert panel[J]. An Bras Dermatol, 2020, 95(2):221-237. DOI PMID
[16]	李增宁, 李晓玲, 陈伟, 等. 肿瘤患者食欲评价和调节的专家共识[J]. 肿瘤代谢与营养电子杂志, 2020, 7(2):169-177.
	Li ZN, Li XL, Chen W, et al. Expert consensus on appetite assessment and regulation in cancer patients[J]. Electron J Metab Nutr Cancer 2020, 7(2):169-177.
[17]	Buske C, Dreyling M, Alvarez-Larrán A, et al. Managing hematological cancer patients during the COVID-19 pandemic:an ESMO-EHA interdisciplinary expert consensus[J]. ESMO Open, 2022, 7(2):100403. DOI URL
[18]	Jazieh AR, Zeitouni M, Alghamdi M, et al. Management guidelines for stage Ⅲ non-small cell lung cancer[J]. Crit Rev Oncol Hematol, 2021, 57:103144.
[19]	Daly ME, Singh N, Ismaila N, et al. Management of stage III non-small-cell lung cancer:ASCO guideline[J]. J Clin Oncol, 2022, 40(12):1356-1384. DOI URL
[20]	Caminiti C, Diodati F, Annunziata MA, et al. Psychosocial care for adult cancer patients:guidelines of the Italian medical oncology association[J]. Cancers(Basel), 2021, 13(19):4878.
[21]	马景双, 王艳杰, 张丽娟, 等. 肺癌术后化疗患者症状群体验的质性研究[J]. 当代护士, 2023, 30(2):117-121.
	Ma JS, Wang YJ, Zhang LJ, et al. A qualitative study of the symptom group experience of patients undergoing chemotherapy after lung cancer[J]. Modern Nurse, 2023, 30(2):117-121.
[22]	Chan CW, Richardson A, Richardson J. Managing symptoms in patients with advanced lung cancer during radiotherapy:results of a psychoeducational randomized controlled trial[J]. J Pain Symptom Manage, 2011, 41(2):347-357. DOI URL
[23]	Chen HM, Cheung DST, Lin YY, et al. Relationships of exercise timing with sleep,fatigue and restactivity rhythms of lung cancer patients in Taiwan:an exploratory study[J]. Eur J Cancer Care(Engl), 2020, 29(4):e13233.
[24]	Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients:the M.D. Anderson Symptom Inventor[J]. Cancer, 2000, 89(7):1634-1646. DOI PMID
[25]	Wang XS, Wang Y, Guo H, et al. Chinese version of the M.D.Anderson symptom inventory[J]. Cancer, 2004, 101(8):1890-1901. DOI URL
[26]	Ware JJ, Snow KK, Kosinski M, et al. SF-36 health survey manual and interpretation guide[M]. Boston: New England Medical Center the Health Institute, 1993:1-12.
[27]	李鲁, 王红妹, 沈毅. SF-36健康调查量表中文版的研制及其性能测试[J]. 中华预防医学杂志, 2002, 36(2):109-113. PMID
	Li L, Wang HM, Shen Y. Development and psychometric tests of a Chinese version of the SF-36 Health Survey Scales[J]. Chin J Prev Med, 2002, 36(2):109-113. PMID
[28]	卢山, 孙小玲, 王静, 等. 多囊卵巢综合征不孕患者治疗期间生活方式管理方案的构建及应用研究[J]. 中华护理杂志, 2023, 58(2):141-149. DOI
	Lu S, Sun XL, Wang J, et al. Construction and application of a lifestyle management scheme for infertile women with polycystic ovary syndrome during medical treatment[J]. Chin J Nurs, 2023, 58(2):141-149.
[29]	李晶晶. 肺癌患者化疗间歇期症状群的管理研究[D]. 太原: 山西医科大学, 2022.
	Li JJ. Study on management of symptom groups in intermittent chemotherapy for lung cancer patients[D]. Taiyuan: Shanxi Medical University, 2022.
[30]	Hung HY, Wu LM, Chen KP. Determinants of quality of life in lung cancer patients[J]. J Nurs Scholarsh, 2018, 50(3):257-264. DOI URL
[31]	王海播, 徐榆林, 李豪, 等. 肺癌化疗患者支持性照护需求现状及影响因素研究[J]. 医药论坛杂志, 2021, 42(19):10-14.
	Wang HB, Xu YL, Li H, et al. Study on the current situation and influencing factors of supportive care needs of lung cancer patients undergoing chemotherapy[J]. J Med Forum, 2021, 42(19):10-14.
[32]	江淀淀, 崔妙玲, 黄维, 等. 肺癌患者就医延迟风险预测模型的构建及验证[J]. 中华护理杂志, 2023, 58(6):682-688. DOI
	Jiang DD, Cui ML, Huang W, et al. Construction and validation of a risk predictive model for treatment delay of patients with lung cancer[J]. Chin J Nurs, 2023, 58(6):682-688. DOI